Abstract
One of the main successes of cellular therapies in the last decade has been the generation of immunomodulating reagents for clinical use. Umbilical cord can be used to source such cell populations. In this chapter we will concentrate on describing the features of and the clinical experience with regulatory T-cells and mesenchymal stromal cells. Although relevant immunomodulating activity can also be ascribed to hematopoietic stem cells, that is the subject of another chapter of this book. Similarly, other populations have been isolated and demonstrated to exhibit immunosuppressive activity but, probably because of their small concentration and the difficulty in their expansion, they have not been developed any further.
Original language | English |
---|---|
Title of host publication | Cord Blood Stem Cells Medicine |
Publisher | ELSEVIER ACADEMIC PRESS INC |
Pages | 125-140 |
Number of pages | 16 |
ISBN (Print) | 9780124078369, 9780124077850 |
DOIs | |
Publication status | Published - 10 Dec 2014 |
Keywords
- Cellular Therapy
- Graft-versus-Host-Disease
- Mesenchymal Stromal Cells
- Regulatory T-cells
- Umbilical cord blood and tissue